BioNTech initiates clinical trial of mRNA-based malaria vaccine candidate
The phase-I trial is expected to enroll 60 volunteers in the United States (US) with no history of malaria to evaluate the vaccine…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.